[HTML][HTML] The Wisconsin Registry for Alzheimer's Prevention: a review of findings and current directions

SC Johnson, RL Koscik, EM Jonaitis, LR Clark… - Alzheimer's & Dementia …, 2018 - Elsevier
Abstract The Wisconsin Registry for Alzheimer's Prevention is a longitudinal observational
cohort study enriched with persons with a parental history (PH) of probable Alzheimer's …

Neuronal cell death mechanisms in Alzheimer's disease: An insight

P Goel, S Chakrabarti, K Goel, K Bhutani… - Frontiers in molecular …, 2022 - frontiersin.org
Regulated cell death (RCD) is an ordered and tightly orchestrated set of changes/signaling
events in both gene expression and protein activity and is responsible for normal …

Effects of aerobic exercise training on systemic biomarkers and cognition in late middle-aged adults at risk for Alzheimer's disease

JM Gaitán, HY Moon, M Stremlau, DB Dubal… - Frontiers in …, 2021 - frontiersin.org
Increasing evidence indicates that physical activity and exercise training may delay or
prevent the onset of Alzheimer's disease (AD). However, systemic biomarkers that can …

Amyloid burden and neural function in people at risk for Alzheimer's Disease

SC Johnson, BT Christian, OC Okonkwo, JM Oh… - Neurobiology of …, 2014 - Elsevier
To determine the relationship between amyloid burden and neural function in healthy adults
at risk for Alzheimer's Disease (AD), we used multimodal imaging with [C-11] Pittsburgh …

Predicting age from cortical structure across the lifespan

CR Madan, EA Kensinger - European Journal of Neuroscience, 2018 - Wiley Online Library
Despite interindividual differences in cortical structure, cross‐sectional and longitudinal
studies have demonstrated a large degree of population‐level consistency in age‐related …

Molecular and imaging biomarkers in Alzheimer's disease: a focus on recent insights

C Villa, M Lavitrano, E Salvatore, R Combi - Journal of Personalized …, 2020 - mdpi.com
Alzheimer's disease (AD) is the most common neurodegenerative disease among the
elderly, affecting millions of people worldwide and clinically characterized by a progressive …

A systematic review of longitudinal studies which measure Alzheimer's disease biomarkers

E Lawrence, C Vegvari, A Ower… - Journal of …, 2017 - content.iospress.com
Alzheimer's disease (AD) is a progressive and fatal neurodegenerative disease, with no
effective treatment or cure. A gold standard therapy would be treatment to slow or halt …

Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease

A Chincarini, F Sensi, L Rei, G Gemme, S Squarcia… - NeuroImage, 2016 - Elsevier
Background Structural MRI measures for monitoring Alzheimer's Disease (AD) progression
are becoming instrumental in the clinical practice, and more so in the context of longitudinal …

Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease

OC Okonkwo, G Xu, JM Oh, NM Dowling… - Cerebral …, 2014 - academic.oup.com
Cerebral blood flow (CBF) provides an indication of the metabolic status of the cortex and
may have utility in elucidating preclinical brain changes in persons at risk for Alzheimer's …

Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes

E Mak, S Gabel, H Mirette, L Su, GB Williams… - Ageing research …, 2017 - Elsevier
The last decade has witnessed a proliferation of neuroimaging studies characterising brain
changes associated with Alzheimer's disease (AD), where both widespread atrophy and …